394-04-7

Usage

Uses

Used in Pharmaceutical Industry:
5-Fluoro-2-methoxybenzoic acid is used as a key intermediate in the synthesis of various pharmaceuticals, including antibiotics, anti-inflammatory drugs, and anticancer agents. Its unique structure allows for the development of new drugs with improved potency and selectivity.
Used in Agrochemical Industry:
5-Fluoro-2-methoxybenzoic acid is also used as an intermediate in the synthesis of agrochemicals, such as herbicides and insecticides. Its incorporation into these compounds can enhance their effectiveness in controlling pests and weeds, leading to increased crop yields and reduced environmental impact.
Used in Organic Synthesis:
5-Fluoro-2-methoxybenzoic acid serves as a versatile building block in organic synthesis, allowing for the preparation of a wide range of organic compounds with diverse applications. Its reactivity and functional group compatibility make it a valuable component in the synthesis of specialty chemicals, dyes, and other materials.
Used in Research and Development:
5-Fluoro-2-methoxybenzoic acid is utilized in research and development settings to explore new chemical reactions and synthetic pathways. Its unique properties and reactivity make it an attractive candidate for studying novel chemical transformations and developing new synthetic methodologies.

InChI:InChI=1/C8H7FO3/c1-12-7-3-2-5(9)4-6(7)8(10)11/h2-4H,1H3,(H,10,11)

Upstream product

• 459-60-9 1-fluoro-4-methoxybenzene 
• 917-54-4 methyllithium 
• 445-82-9 1-(5-fluoro-2-methoxyphenyl)ethanone 
• 399-54-2 4-fluoro-2-methylanisole 
• 109-72-8 n-butyllithium 
• 60-29-7 diethyl ether 
• 124-38-9 carbon dioxide 
• 452-71-1 4-fluor-2-methylaniline 
• 452-72-2 4-fluoro-2-methylphenol 
• 151793-20-3 methyl 5-fluoro-2-methoxybenzoate 
• 345-16-4 5-fluoro-2-hydroxybenzoic acid 
• 394-32-1 1-(5-fluoro-2-hydroxyphenyl)ethan-1-one 

Downstream Products

• 345-16-4 5-fluoro-2-hydroxybenzoic acid 
• 1744-11-2 5-fluoro-2,N-dihydroxy-benzamide 
• 1207283-56-4 phenyl 6-{[(tert-butoxy)carbonyl]oxy}-3-fluoro-2-methylbenzoate 
• 1207283-57-5 (1R,3S,4S,11S)-8-(benzyloxy)-11-[(tert-butyldimethylsilyl)oxy]-4-(dimethylamino)-19-fluoro-12-hydroxy-10,14-dioxo-6-oxa-7-azapentacyclo[11.8.0.0.(3,11)0.(5,9)0(15,20)]henicosa-5-⁽⁹⁾,7,12,15⁽²⁰⁾,16,18-hexaen-16-yl tert-butyl carbonate 
• 1207283-58-6 (1R,3S,4S,11S)-8-(benzyloxy)-4-(dimethylamino)-19-fluoro-11,12,16-trihydroxy-6-oxa-7-azapentacyclo-[11.8.0.0.(3,11)0.(5,9)0(15,20)]henicosa-5⁽⁹⁾,7,12,15⁽²⁰⁾,16,18-hexaene-10,14-dione 
• 371-41-5 4-Fluorophenol 
• 579-75-9 2-Methoxybenzoic acid 

Relevant academic research and scientific papers

INHIBITORS OF THE MENIN-MLL INTERACTION

The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.

Leukotriene A4 hydrolase and cyclooxygense double target inhibitors and use thereof

The invention discloses a double-target inhibitor for leukotriene A4 hydrolase and cyclooxygenase as well as a purpose of the double-target inhibitor. The double-target inhibitor is a compound shown in a general formula (I), wherein X1 and X2 are respectively and independently separated into hydrogen, halogen, alkyl or alkoxy; Y represents hydrogen, hydroxyl, halogen or alkyl; Z represents substituent groups at the fourth position and/or the fifth position of a benzoyl core benzene ring, and respectively represents hydrogen, halogen, amino, alkyl acylamino, alkyl substituted amino, trifluoromethyl or carboxyl alkyl acylamino; n is 2 to 4. The compound can be used for preparing medicine for treating, preventing or inhibiting inflammation such as arthritis and rheumatoid arthritis.